Daniel J. Livorsi

2.4k citations
92 papers · 1.6k indexed · h-index 23
Topics
Antibiotic Use and Resistance (47 papers)Patient Satisfaction in Healthcare (32 papers)Bacterial Identification and Susceptibility Testing (22 papers)
Journals
SHILAP Revista de lepidopterologíaClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy

In The Last Decade

Daniel J. Livorsi

84 papers receiving 1.5k citations

Peers

Daniel J. Livorsi
Comparison fields: 5 of 113
  • Infectious Diseases 576
  • Applied Microbiology and Biotechnology 494
  • Epidemiology 468
  • Public Health, Environmental and Occupational Health 338
  • Clinical Biochemistry 330
Replace Sarah K. Parker with:
Sarah K. Parker United States
Timothy C Jenkins United States
Michael Borg Malta
Lisa Davidson United States
Caroline Marshall Australia
Christopher J. Graber United States
Jason G. Newland United States
Mary P. Kearney United Kingdom
Stig Harthug Norway
Michelle T. Hecker United States
Daniel J. Livorsi relative to Sarah K. Parker United States Sarah K. Parker's profile →
Citations per field
00.5×1.7×
Sarah K. Parker · 1×
Citations per year

Countries citing papers authored by Daniel J. Livorsi

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Livorsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Livorsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Livorsi more than expected).

Fields of papers citing papers by Daniel J. Livorsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Livorsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Livorsi. The network helps show where Daniel J. Livorsi may publish in the future.

Co-authorship network of co-authors of Daniel J. Livorsi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Livorsi. A scholar is included among the top collaborators of Daniel J. Livorsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Livorsi. Daniel J. Livorsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 0
5 8
6 13
7 1
8 6
9 1
10 1
11 7
12 2
13 2
14 7
15 28
16 4
17 3
18 28
19 90
20 5

About Daniel J. Livorsi

Daniel J. Livorsi is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Molecular Medicine, having authored 92 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (47 papers), Patient Satisfaction in Healthcare (32 papers) and Bacterial Identification and Susceptibility Testing (22 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (494 citations), Clinical Biochemistry (330 citations) and Molecular Medicine (207 citations). Daniel J. Livorsi has collaborated with scholars based in United States, Brazil and Canada. Frequent co-authors include Eli N. Perencevich, Michihiko Goto, Naasha J Talati, Melissa Osborn, Krutika Kuppalli, Marin L. Schweizer, Rajeshwari Nair, Bruce Alexander, Michael Ohl and Brett H. Heintz. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026